Cancer Genetics

Article	Citations
64. A rare finding of triple KRAS mutations with OmniSeq® INSIGHT in a patient with colorectal adenocarcinoma	291
43. Challenges of classifying variants associated with disorders of somatic mosaicism and guideline creation	101
40. Prioritization of defining and supportive diagnostic variants in pediatric tumors	67
LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185–5p/PLOD1/Akt/mTOR pathway	46
2. Diagnostic next generation sequencing to detect MYD88 L265P in lymphoplasmacytic lymphoma compared to ddPCR	39
Exploring the role of transcription factor TWIST1 in bladder cancer progression	39
Detection of VHL variant on multigene panel testing for hereditary breast cancer: Implications for genetic counselling	36
Upregulation of Uracil DNA Glycosylase (UNG) in Prostate Cancer	30
135. Tumor deconvolution using comprehensive single-cell RNA sequencing cell type signatures	29
13. HPV forms chimeric virus-human transcripts that affect host gene expression in cervical tumors	24
27. Five-year experience of evaluating individuals at-risk for underlying genetic predisposition to hematologic malignancy	23
116. Integrating methylation profiling into adult brain tumor diagnostics - the Australian experience	21
96. A unique case presentation of pediatric spinal ependymoma with chromothripsis of chromosome 6: case report	20
58. Improving the molecular diagnosis of SBDS-related disorders by identifying rare gene conversion events.	19
Molecular determinants of clinical outcomes for anaplastic lymphoma kinase–positive non-small cell lung cancer in Chinese patients: A retrospective study	18
49. Clinical validation of Infinium CytoSNP-850K SNP-Array for routine copy number profiling of hematological malignancies	17
17. Multi-consortia initiative to standardize the representation and curation of oncogenic fusions	17
26. An ATIC::ALK fusion created by balanced insertion rather than inversion of chromosome 2 in an ALK+ anaplastic large cell lymphoma	15
The hsa-miR-516a-5p and hsa-miR-516b-5p microRNAs reduce the migration and invasion on T98G glioblastoma cell line	14
Expression and clinical significance of the imprinted gene PHLDA2 in colorectal cancer	14
15. Clinical impact of in-house molecular testing for underserved cancer patients in southern Alabama	13
Ewing sarcoma of the rib with a rare PTEN mutation	13
36. Significant copy number variants and loss of heterozygosity in Wilms Tumor: Insights from Nationwide Pediatric Oncology	13
Corrigendum to “Ultra-sensitive detection of melanoma NRAS mutant ctDNA based on programmable endonucleases” [Cancer Genetics 294-295 (2025) 47–56]	12
The multidimensional role of laminin γ2 (LAMC2) on cancer progression	12

70. Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia	11
56. Variants of established clinical significance: Progress and challenges in the VECS SC-VCEP	11
Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer	10
Three FGFR4 gene polymorphisms contribute to the susceptibility of urethral cancer in the middle and south of Iraq population	10
13. Remember breakpoint two: Enhancer swapping, a frequent deleterious consequence of balanced chromosomal rearrangements	10
Mutation status in yes-associated protein 1 (YAP1) in an insulinoma cell line Rin-5F	10
74. Genetic and functional characterization of complex chromosomal rearrangements in a family with multisystem anomalies	9
102. Using cytogenomics to distinguish two types of renal cell carcinoma in a composite or collision tumor	9
104. A hematologic case with germline deletion of PMS2 and increased risk of HNPCC studied by optical genome mapping and NGS	9
129. Standardization of cancer terminology in the Mondo Disease Ontology	9
99. Histopathologic Correlation Somatic Variants in Non Small Cell Lung Cancer with High Tumor Mutation Burden	9
Distinct mechanisms of PTEN inactivation in dogs and humans highlight convergent molecular events that drive cell division in the pathogenesis of osteosarcoma	9
61. Clinical whole exome/whole transcriptome analysis detects clinically relevant structural alterations in Multiple Myeloma	8
3. Application of optical genome mapping to identify samples with homologous recombination deficiency	8
28. Trisomy 21 silencing in hematopoietic and neural cells: New insights and prospects	8
14. Concurrent systemic mastocytosis and T-lymphoblastic lymphoma unified by a novel cryptic JAKMIP2::PDGFRB rearrangement	8
17. Deconvolution of genetic heterogeneity in Glioblastoma using multi-region sampling	8
Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature	8
A rare CALR variant mutation and efficient peginterferon alfa-2a response in a patient with essential thrombocythemia	8
4. Comprehensive next generation cytogenomics improves risk stratification of acute myeloid leukemia	8
Comprehensive analysis of PLKs expression and prognosis in breast cancer	8
Double heterozygous pathogenic variants in the BRCA1 and BRCA2 genes in a patient with bilateral metachronous breast cancer	8
16. International working group recommendations for the implementation of optical genome mapping in Hematologic Malignancies	7
A complex t(15;22;17)(q22;q11.2;q21) variant of APL	7
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues	7
6. Optical genome mapping as a potential Tier1 test for Postnatal Chromosomal Disorders – results of multi-institutional validation study of 331 retrospective clinical samples	7
8. Harnessing the power of microarray in the analysis of rarer pediatric sarcomas	7
60. AI-guided histopathology predicts brain metastasis in lung cancer patients	7
31. Rare familial rearrangement with acrocentric satellite material on Yp relocating to Xp in a female fetus	7
Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs)	7
Prognosis prediction and drug guidance of ovarian serous cystadenocarcinoma through mitochondria gene-based model	7
37. Epigenetic reprogramming of brain development pathways during non-small cell lung cancer metastasis to brain	6
38. Formation of a tumor-specific gene list: The Central Nervous System (CNS) tumor taskforce experience	6
Clinical management of TP53 mosaic variants found on germline genetic testing	6
22. Cell-free DNA genomic and epigenomic analysis to predict survival in mCRPC patients treated with AR-directed therapy	6
9. Best practices for testing and reporting of FISH studies in multiple myeloma: Recommendations from the CGC working group	6
79. Implications of fortuitous detection of JAK2 V617F mutations with solid tumor clinical sequencing	6
76. Goals, methods and challenges in a clinical validation of a NGS-based platform for the detection of constitutional CNVs	6
Corrigendum to “Omics approaches: Role in acute myeloid leukemia biomarker discovery and therapy” [Cancer Genetics, 2025, Volume: 292-293, Pages: 14-26/https://doi.org/10.1016/j.cancergen.2024.12.006]	6
18. Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia	6
139. Feasibility of comprehensive whole genome profiling in hematological malignancies	5
32. Clinical utility and feasibility of adopting optical genome mapping for chromosomal characterization of solid tumors	5
53. Uveal melanoma - The New Zealand perspective	5
44. Clinical utility of pharmacogenomics testing with an expanded panel	5
Cryptic KMT2A/MLLT10 fusion detected by next-generation sequencing in a case of pediatric acute megakaryoblastic leukemia	5
14. Four-way translocation in a patient with mild clitoromegaly	5
Is 5q deletion in de novo Acute Myelogenous Leukemia (AML) with excess blasts a surrogate marker for the cryptic t(7;21)(p22;q22)? A case report and review of literature	5
31. A cross-consortia initiative for aligning the definitions and descriptions of gene fusions	5
63. Comparative analysis of testing methods used for the detection of internal tandem duplications in the KMT2A/MLL gene	5
Exosomal DNMT1 mRNA transcript is elevated in acute lymphoblastic leukemia which might reprograms leukemia progression	5

Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome	5
50. Chromosomal microarray uncovers novel mechanisms of progression in myelodysplastic syndromes with normal karyotype	5
7. Overview of recurrent and novel gene fusions detected in a clinical diagnostic laboratory	5
Identification of BRIP1, NSMCE2, ANAPC7, RAD18 and TTL from chromosome segregation gene set associated with hepatocellular carcinoma	4
65. Insights into the genetic heterogeneity of glioblastoma: gene amplification in ecDNA and HSR	4
A rare case of atypical chronic myeloid leukemia associated with t(8;22)(p11.2;q11.2)/ BCR-FGFR1 rearrangement: A case report and literature review	4
16. Uniparental disomy (UPD) of multiple chromosomes in two cases with a complex phenotype	4
LncRNA SNHG29 Suppresses Epithelial Ovarian Cancer Cell Invasion and Migration via miR-20b-3p/GNAI3 Axis Regulation	4
24. Tissue-based sequencing for laboratory diagnosis of Somatic Mosaic Disorders	4
Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2)	4
Necessity of multiplex ligation probe amplification in genetic tests: Germline variant analysis of the APC gene in familial adenomatous polyposis patients	4
Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic Leukemia.	4
TERT gene rearrangement in chordomas and comparison to other TERT-rearranged solid tumors	4
77. dic(7;9):A distinct entity in B-ALL with multiple genomic aberrations including IKAROS and PAX5	4
26. Co-occurrence of rosette-forming glioneuronal tumors with Noonan Syndrome	4
120. Expert curation of FLT3 variants by the ClinGen FLT3 Somatic Cancer Variant Curation expert panel	4
Editorial Board	4
Rare and potentially fatal ‐ Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in children	4
66. Optical genome mapping workflow for Somatic Abnormality detection in Multiple Solid Tumor types	4
2. Clinical, cytogenetic and genomic profiling of B-Other Acute Lymphoblastic Leukemia: An Indian cohort study	4
7. Optical genome mapping for prenatal diagnostic testing	3
45. Clonal hematopoiesis in childhood cancer survivors	3
Editorial Board	3
30. Semi-automated approaches for digital pathology analyses standardize pathologic assessment of clinical melanoma biopsies	3
57. A rare case of near-tetraploidy in CLL: An investigation by MLPA, FISH, and chromosome analysis	3
ADAR1 gene expression and its importance in breast cancer	3
Composite mantle cell lymphoma with cryptic ins(11;2)(q13;p11.2p11.2)/IGK::CCND1 and lymphoplasmacytic lymphoma with MYD88 L265P mutation	3
18. Trisomy 18p detected in DNA from saliva but absent in DNA from blood	3
56. Optical genome mapping reveals genomic complexity and detects novel genetic abnormalities in T-Lymphoblastic Leukemia	3
Editorial Board	3
24. Donor-derived acute myeloid leukemia in a recipient of liver-transplantation	3
Lynch syndrome caused by a novel deletion of the promoter and exons 1–13 of MLH1 gene	3
127. Characterization of alternative transcription start and termination sites in glioblastoma	3
78. Next generation cytogenomics improves patient risk stratification in acute myeloid leukemia	3
Unraveling complex karyotype clonal architecture: co-existing double TP53 mutations alongside DNMT3A, TET2, and NF1 mutations – a case study	3
A comparison of WHO-5 and ICC classifications in a series of myeloid neoplasms, considerations for hematopathologists and molecular pathologists	3
22. Reducing diagnostic FISH turn-around-time: A rapid pipeline for BCR::ABL1 and PML::RARA suspected leukemias	3
Hypomethylation of DRD2 promotes breast cancer through the FLNA-ERK pathway	3
77. Mining COSMIC for frameshift neoantigens as `off-the-shelf' therapeutic cancer vaccine candidates	3
94. Initial efforts of the ClinGen Solid Tumor Taskforce in promoting variant curation in solid tumors into CIViC	3
4. Glioblastomas with MAPK pathway alterations show low grade histologic features and present novel therapeutic targets	3
HRD status variation in consecutive tumour biopsies in a pan-cancer cohort: a descriptive single-center study including patients from the Phase 1 Unit, Copenhagen University Hospital, Rigshospitalet	3
Corrigendum to “RNF121 Promotes the Proliferation, Migration, and Invasion of Non-Small-Cell lung cancer cell lines” [Cancer Genetics 298-299 (2025) 193-197]	3
12. The landscape of structural variation discovery and interpretation across global populations and the developmental continuum	3
Dysregulation of metallothionein MT1 sub-types in TCF3::PBX1 pre-B-cell acute lymphoblastic leukemia	2
21. Translating human readable variation descriptions to unique computable variations with the Variation Normalizer	2
75. Clinical implementation of a precision medicine consultation service	2
The oncogenic roles of NTRK fusions and methods of molecular diagnosis	2
Mechanistic study of Liquiritigenin inhibiting bladder cancer cell proliferation and migration by regulating STING1	2
Metabolic–related gene signatures for survival prediction and immune cell subtypes associated with prognosis in intrahepatic cholangiocarcinoma	2
Mesothelin CAR‐T cells secreting PD‐L1 blocking scFv for pancreatic cancer treatment	2
89. TCF3::ZNF384 in a Peruvian girl with mixed-phenotype acute leukemia and poor treatment outcome	2
Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-MYH11 acute myeloid leukemia	2
Mutations of ARID1B, PIK3C2B, KMT2B, and FAT1 genes influence clinical outcome in newly diagnosed myeloma	2
34. A molecular and clinicopathologic analysis of primary intracranial sarcomas	2
7. AI-Based Algorithms for neoplastic metaphase cells boost efficiencies in the cytogenetics laboratory	2
98. A bioinformatics analysis of differentially expressed genes in non-small cell lung cancer subtypes	2
24. Clinical utility of optical genome mapping: comparison with standard cytogenomics work-up for hematological malignancies	2
Biological landscape of human papilloma virus-related head and neck cancer according to virus genotype	2
In silico protein structural analysis of PRMT5 and RUVBL1 mutations arising in human cancers	2
Clonal Cytogenetic Abnormality in IgG4-Related Disease	2
66. Screening for genetic predisposition to pediatric leukemia in a Peruvian population	2
Mast cell leukemia with novel BRAF variant and concomitant atypical KIT variant	2
74. Dilemma of selecting the optimal diagnostic test(s) for genetic biomarkers in hematologic malignancies	2
93. Surveying the genomic landscape of Mantle Cell Lymphoma	2
28. Analytical validation of an optical genome mapping assay for structural variant detection in hematologic malignancies	2
9. The dual PI3K inhibitor duvelisib potently inhibits cytokine release syndrome while maintaining CAR-T function	2
Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation	2
24. Methylation sequencing enhances interpretation of clonal hematopoiesis dynamics	2
83. Cytogenetic and molecular characterization of IDH-mutant adult-type diffuse gliomas with near-total 1p/19q co-deletions	2
Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy	2
20. Diagnostic utility and lessons learned from deep sequencing vascular malformations	2
43. Fusion Curation Interface: an educational tool to explore a unified framework for representing & curating gene fusions	1
Half of most frequently mutated genes in breast cancer are expressed differentially between premenopausal and postmenopausal breast cancer patients	1
43. Association between Clonal Hematopoiesis and Inherited Cancer Susceptibility Genes	1
4. Current applications of cell-free DNA in pregnancy and oncology	1
Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel	1
TRIM29 promotes glioblastoma progression via ubiquitinating NEFL and activating the PI3K/AKT signaling pathway	1
20. Comparative analysis of RNA expression identifies druggable targets in difficult-to-treat pediatric solid tumors	1
12. Contextualizing clinical significance using FDA label supplemented DGI data	1

90. TERT promoter mutation detection by ddPCR in glial atypia	1
91. Atypical BCR::ABL1 rearrangements identified by optical genome mapping in patients with chronic myeloid leukemia	1
133. Incidental finding of the 1st degree of parental relatedness in a newborn with JBS and homozygous UBR1 mutation	1
53. Clinical whole exome/whole transcriptome (WES/WTS) analysis detects copy number and structural rearrangements important	1
Mismatch Repair Cancer Syndrome presenting as synchronous high-grade glioma and diffuse large B cell lymphoma in a pediatric patient	1
131. Clonal Hematopoiesis is associated with risk of Cardiovascular Disease in individuals with Human Immunodeficiency Virus	1
Potential use of SCAT1, SCAT2, and SCAT8 as diagnostic and prognosis markers in colorectal cancer	1
50. Molecular profiling of Cytolyt-Fixed FNA washes to improve diagnostic yield in lung cancer	1
62. Characterization of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) with KMT2A amplification	1
134. Novel fusions in aggressive infant sarcomas: Expanding the scope of 'CIC-rearranged' sarcoma without CIC rearrangement	1
5. Implementation of Automatic Slide Processing for Aneuploidy FISH Test	1
Unfavorable disease progression in patients with chronic myeloid leukemia and concurrent t(6;9) translocation (DEK::NUP214 fusion) or inversion 16 (CBFB::MYH11 fusion)	1
Evaluating the consistency of SMARCB1 variant classification and assertions of genotype-phenotype relationships in ClinVar	1
The role of miR-10b-5p in prostate cancer and its exosome-mediated angiogenesis effect	1
High YEATS4 expression characterizes MDM2-amplified liposarcoma	1
Influence of IL-38 as a novel biomarker on the pathophysiological processes of esophageal cancer	1
94. Comparison of FISH to whole exome/whole transcriptome detection of relevant structural alterations in Multiple Myeloma	1
The promise of TRK inhibitors in pediatric cancers with NTRK fusions	1
Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma	1
65. Creating a common language for categorical variants	1
Evaluation of DNA methylation in promoter regions of hTERT, TWIST1, VIM and NID2 genes in Moroccan bladder cancer patients	1
42. MDM2 and centromere 12 co-amplification presents diagnostic challenge in low grade adipocytic tumors	1
46. Integrative cytogenetic and molecular studies unmasks `chromosomal mimicry' in hematologic malignancies	1
9. Optical genome mapping workflow for identification and annotation of variants in hematological malignancy	1
Prelims	1
81. Discrepancies in the detection of PML::RARA gene rearrangement by FISH using commonly used dual-color dual-fusion probes	1
82. Can mitochondrial DNA mutations be used as a biomarker for endometrial cancer?	1
16. ClinGen Cancer Variant Interpretation (CVI) Committee: Pilot guidance for somatic cancer variant curation expert panels	1
130. The Myeloid Malignancy Variant Curation Expert Panel: Investigating RUNX1, GATA2, and DDX41	1
63. A female-specific chimeric RNA with differential expression in COVID patients	1
Synchronous driver gene alterations (EGFR L858R, T790M, and ROS1) rearrangements in a patient with early-stage lung adenocarcinoma	1
8. Optical genome mapping analysis of FMR1 expansions in fragile X syndrome	1
Investigation of discordant sibling pairs from hereditary breast cancer families and analysis of a rare PMS1 variant	1
105. Clinical whole-genome sequencing identifies NSD3 as the correct fusion partner of NUP98 in a patient with acute myeloid	1
Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma	1
53. Microarray-based 'rescue' of failed karyotype testing	1
23. Complementarity of RNA sequencing and optical genome mapping in detection of rare fusions in pediatric B-ALL	1
48. Targeted RNA-Seq on fresh frozen and methanol/acetic acid fixed cells in diagnostic workup of hematologic malignancies	1
When cascade testing for familial variant seems inadequate to provide clinically actionable information for blood relatives	1
41. Step 2 updates for the oncogenic assessment of FLT3 variants by the ClinGen FLT3 somatic cancer variant curation expert	1
38. Oncogenic evidence in the CIViC data model	1
38. Assessment of TRG and TRB clonality by NGS of dermatologic specimens is impacted by biopsy type, DNA and amplicon sizes	1
128. Clinical testing of mismatch repair in neoplasms using multiple laboratory methods	1
The mechanism of lncRNA SSTR5-AS1 promoting ferroptosis resistance and immune escape in ovarian cancer cells by recruiting STAT3 to regulate SLC7A11 expression	1
The prognostic, diagnostic, and therapeutic impact of Long noncoding RNAs in gastric cancer	1
Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA	1
85. Microfilter enrichment of Hodgkin and Reed-Sternberg (HRS) cells	1
Regulator of G-protein signaling 14 (RGS14) promotes cancer growth in hepatocellular carcinoma	1
103. Formation of a ClinGen Variant Curation Expert Panel (VCEP) dedicated to Oncohistone H3 Variants in Pediatric Gliomas	1
6. Emerging clinically-relevant applications of ultra-sensitive mutation detection	1
24. Archer system copy number alteration caller: User experience	1
55. Clinical validation and implementation of exome, transcriptome and whole genome sequencing for pediatric cancers	1
36. Clinical utility of copy number alteration analysis in the evaluation of Melanocytic Lesions for diagnosis and prognosis	1
11. Evaluation of Hi-C versus optical genome mapping for diagnosing constitutional genomic structural variants	1
BRCA1 and BRCA2 whole cDNA analysis in unsolved hereditary breast/ovarian cancer patients	1
138. Optical Genome Mapping workflow for identification and analysis of variants in Hematological Malignancies	1
83. Quantum lattices for early cancer detection through machine learning	1
79. Extraction of multiple analytes in liquid biopsy may improve the diagnosis of breast cancer	1
30. Current next generation sequencing reporting practices: A GOAL Consortium report	1
96. Dissection of the expressed actionable fusions' repertoire in solid tumors in a clinical setting across 14 cancer types	1
68. Orthogonal approaches to validate a knowledgebase of interpretations of clinically relevant somatic cancer variants	1
3. Optical genome mapping reveals novel structural variants in pediatric high grade gliomas	1
Editorial Board	1
100. Ultrasensitive molecular residue disease detection enabled by genome wide concatemer error correction	1
59. Constellation of rare genetic abnormalities associated with MECOM rearrangement in AML	1
PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas	1
The effect of HOTAIR gene variants on the development of bladder cancer and its clinicopathological characteristics in a Caucasian population	1
1. Enrichment of Hodgkin and Reed-Sternberg (HRS) cells using size-based microfiltration	1
The impact of extracellular vesicles on breast cancer metastasis and therapeutics: genetic considerations	1
Ellagic acid inhibits EZH2: a potential epigenetic therapeutic molecule for cancer	1
107. MyVariant.info: a gateway to integrated resource of variant annotations	1
SP1-induced circ_0017552 modulates colon cancer cell proliferation and apoptosis via up-regulation of NET1	1
Acute cardiac dysfunction in patients with ovarian cancer treated with Niraparib due to TFAM mutation: A case series and functional analysis	1
41. Participant reflections from the program for evaluation of Ashkenazi Jewish Cancer heritability involving the BRCA genes	1
64. FAIR sharing of cancer GWAS data via the NHGRI-EBI GWAS catalog	0
13. Implementation of new ClinGen/CGC/VICC recommendations for classification of oncogenicity of somatic variants using AI	0
35. Integrated comprehensive genomic profiling of meningiomas: A single institutional study	0
10. SNP microarray analysis of over 7,500 myeloid patients: Implications, importance and suggestions for standard of care	0
Synergistic dual oncogenic role of CKS2 and ACAT2: Enhanced regulatory coherence and biomarker potential in adrenocortical carcinoma	0
Identification and characterization of ADAR1 mutations and changes in gene expression in human cancers	0
27. Somatic genomic testing and variant curation practices in Australian and New Zealand diagnostic testing laboratories	0
4. Integrated genetic risk assessment in De-novo Acute Myeloid Leukemia in children and young adults	0
2. Personalized sequencing assays for cerebrospinal fluid liquid biopsies in children with brain tumors	0
67. An undiagnosed chronic myeloid leukemia (CML) with p190 BCR::ABL1 transcript, an extra Philadelphia chromosome, and IKARO	0
72. Comprehensive genomic profiling in the diagnosis of Central Nervous System tumors	0
t(10;12)(q24;q15): A new cytogenetic marker in hematological malignancies	0
Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform	0
BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screening	0
111. pVACsplice: Predicting neoantigens from tumor-specific alternative splicing events derived from regulatory mutations	0
42. Optical genome mapping and 523-gene sequencing panel for comprehensive genomic evaluation of myeloid cancers	0
Molecular subtyping and immune score system by a novel pyroptosis-based gene signature precisely predict immune infiltrating, survival and response to immune-checkpoint blockade in breast cancer	0
Influence of germline test results on surgical decision making in women with invasive breast cancer	0
88. Clinical impact of targeted genomic profiling	0
Editorial Board	0
Genetic profile in primary tumor tissue of advanced lung adenocarcinoma patients with adrenal metastasis	0